Biotech Innovation

Showing 885 articles
Business

ACADIA Pharmaceuticals: A Deep Value Play or a Value Trap?

After a significant rebound, ACADIA Pharmaceuticals (ACAD) shares present a conundrum for investors. While a discounted cash flow model suggests deep undervaluation, the stock's volatile history and mixed performance metrics demand a closer look at the underlying narrative.

Business

REV Group Merges Into Terex, Shifting Investor Landscape and Strategic Focus

The completion of REV Group's merger with Terex Corporation marks a significant corporate realignment, moving the specialty vehicle manufacturer from a standalone NYSE listing to a subsidiary within a larger industrial equipment platform. This restructuring alters how investors track performance and assess exposure to key markets like emergency services and recreational vehicles.

Business

FedEx CEO Charts Cautious Path on Robotics, Bets Big on AI for Global Network

While aggressively deploying AI across its vast logistics network, FedEx is taking a measured, pilot-stage approach to warehouse automation and drones, CEO Raj Subramaniam tells The New York Times. The shipping giant, handling $2 trillion in global commerce, prioritizes scalable infrastructure over unproven robotics for its 17 million daily packages.